| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | semaphorin receptor activity | 3.45e-05 | 12 | 110 | 3 | GO:0017154 | |
| GeneOntologyBiologicalProcess | semaphorin-plexin signaling pathway | 7.66e-06 | 52 | 108 | 5 | GO:0071526 | |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | ERBB2 B4GAT1 KIF1A FAT3 NFASC SIN3A PLXNB2 B4GALT6 SEMA3D PTPRS HPRT1 CNTNAP2 MACF1 PLXNA1 PLXNA2 | 8.18e-06 | 748 | 108 | 15 | GO:0048667 |
| GeneOntologyBiologicalProcess | cell morphogenesis | ERBB2 B4GAT1 KIF1A FAT3 NFASC NOX4 SIN3A PLXNB2 B4GALT6 LIFR SEMA3D PTPRS HPRT1 ARL13B CNTNAP2 MACF1 FMNL1 PLXNA1 PLXNA2 | 1.29e-05 | 1194 | 108 | 19 | GO:0000902 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | ERBB2 B4GAT1 KIF1A NFASC SIN3A PLXNB2 B4GALT6 LIFR SEMA3D PTPRS HPRT1 CNTNAP2 MACF1 PLXNA1 PLXNA2 | 1.86e-05 | 802 | 108 | 15 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | ERBB2 B4GAT1 KIF1A NFASC SIN3A PLXNB2 B4GALT6 LIFR SEMA3D PTPRS HPRT1 CNTNAP2 MACF1 PLXNA1 PLXNA2 | 2.37e-05 | 819 | 108 | 15 | GO:0120039 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | ERBB2 B4GAT1 KIF1A NFASC SIN3A PLXNB2 B4GALT6 LIFR SEMA3D PTPRS HPRT1 CNTNAP2 MACF1 PLXNA1 PLXNA2 | 2.62e-05 | 826 | 108 | 15 | GO:0048858 |
| GeneOntologyBiologicalProcess | axonogenesis | ERBB2 B4GAT1 NFASC SIN3A PLXNB2 B4GALT6 SEMA3D PTPRS CNTNAP2 MACF1 PLXNA1 PLXNA2 | 4.13e-05 | 566 | 108 | 12 | GO:0007409 |
| GeneOntologyBiologicalProcess | axon development | ERBB2 B4GAT1 NFASC SIN3A PLXNB2 B4GALT6 SEMA3D PTPRS CNTNAP2 MACF1 PLXNA1 PLXNA2 | 1.36e-04 | 642 | 108 | 12 | GO:0061564 |
| GeneOntologyCellularComponent | semaphorin receptor complex | 5.00e-07 | 13 | 110 | 4 | GO:0002116 | |
| MousePheno | abnormal CNS glial cell morphology | ERBB2 B4GAT1 CANX MDGA2 PLXNB2 LIFR HPRT1 CNTNAP2 ZFYVE26 PLXNA1 | 1.42e-05 | 272 | 94 | 10 | MP:0000952 |
| MousePheno | abnormal glial cell morphology | ERBB2 B4GAT1 CANX LAMA4 MDGA2 PLXNB2 LIFR HPRT1 CNTNAP2 ZFYVE26 PLXNA1 | 1.96e-05 | 345 | 94 | 11 | MP:0003634 |
| Domain | - | 1.38e-06 | 95 | 109 | 7 | 2.60.120.200 | |
| Domain | ConA-like_dom | 5.49e-06 | 219 | 109 | 9 | IPR013320 | |
| Domain | Plexin_cytopl | 1.58e-05 | 9 | 109 | 3 | PF08337 | |
| Domain | Plexin_cytoplasmic_RasGAP_dom | 1.58e-05 | 9 | 109 | 3 | IPR013548 | |
| Domain | Plexin | 1.58e-05 | 9 | 109 | 3 | IPR031148 | |
| Domain | Semap_dom | 3.06e-05 | 31 | 109 | 4 | IPR001627 | |
| Domain | SEMA | 3.06e-05 | 31 | 109 | 4 | PS51004 | |
| Domain | Sema | 3.06e-05 | 31 | 109 | 4 | SM00630 | |
| Domain | Sema | 3.06e-05 | 31 | 109 | 4 | PF01403 | |
| Domain | FN3_dom | 3.10e-05 | 209 | 109 | 8 | IPR003961 | |
| Domain | Distrobrevin | 3.37e-05 | 2 | 109 | 2 | IPR017432 | |
| Domain | Plexin_repeat | 3.48e-05 | 32 | 109 | 4 | IPR002165 | |
| Domain | PSI | 3.48e-05 | 32 | 109 | 4 | PF01437 | |
| Domain | FN3 | 1.06e-04 | 185 | 109 | 7 | SM00060 | |
| Domain | PSI | 1.24e-04 | 44 | 109 | 4 | IPR016201 | |
| Domain | - | FLNC NFASC MDGA2 PLXNB2 SNED1 LIFR SEMA3D CILP2 PTPRS ROS1 IGSF9B PLXNA1 PLXNA2 | 1.29e-04 | 663 | 109 | 13 | 2.60.40.10 |
| Domain | PSI | 1.48e-04 | 46 | 109 | 4 | SM00423 | |
| Domain | FN3 | 1.67e-04 | 199 | 109 | 7 | PS50853 | |
| Domain | Ig-like_fold | FLNC NFASC MDGA2 PLXNB2 SNED1 LIFR SEMA3D CILP2 PTPRS ROS1 IGSF9B PLXNA1 PLXNA2 | 2.39e-04 | 706 | 109 | 13 | IPR013783 |
| Domain | fn3 | 3.76e-04 | 162 | 109 | 6 | PF00041 | |
| Domain | EF-hand_dom_typ1 | 4.99e-04 | 6 | 109 | 2 | IPR015153 | |
| Domain | EF-hand_dom_typ2 | 4.99e-04 | 6 | 109 | 2 | IPR015154 | |
| Domain | EF-hand_2 | 4.99e-04 | 6 | 109 | 2 | PF09068 | |
| Domain | EF-hand_3 | 4.99e-04 | 6 | 109 | 2 | PF09069 | |
| Domain | IPT | 5.11e-04 | 27 | 109 | 3 | SM00429 | |
| Domain | PLA2_B | 6.95e-04 | 7 | 109 | 2 | PF01735 | |
| Domain | PLA2C | 6.95e-04 | 7 | 109 | 2 | PS51210 | |
| Domain | LysoPLipase_cat_dom | 6.95e-04 | 7 | 109 | 2 | IPR002642 | |
| Domain | PLAc | 6.95e-04 | 7 | 109 | 2 | SM00022 | |
| Domain | TIG | 7.72e-04 | 31 | 109 | 3 | PF01833 | |
| Domain | IPT | 8.48e-04 | 32 | 109 | 3 | IPR002909 | |
| Domain | PTEN_C2 | 9.24e-04 | 8 | 109 | 2 | PF10409 | |
| Domain | PTEN_C2 | 9.24e-04 | 8 | 109 | 2 | SM01326 | |
| Domain | C2_TENSIN | 9.24e-04 | 8 | 109 | 2 | PS51182 | |
| Domain | Tensin_lipid_phosphatase_dom | 9.24e-04 | 8 | 109 | 2 | IPR029023 | |
| Domain | Tensin_C2-dom | 9.24e-04 | 8 | 109 | 2 | IPR014020 | |
| Domain | PPASE_TENSIN | 1.18e-03 | 9 | 109 | 2 | PS51181 | |
| Domain | LAM_G_DOMAIN | 1.41e-03 | 38 | 109 | 3 | PS50025 | |
| Domain | Laminin_G_2 | 1.63e-03 | 40 | 109 | 3 | PF02210 | |
| Domain | Fol_N | 1.79e-03 | 11 | 109 | 2 | IPR003645 | |
| Domain | FOLN | 1.79e-03 | 11 | 109 | 2 | SM00274 | |
| Domain | LamG | 2.15e-03 | 44 | 109 | 3 | SM00282 | |
| Domain | C2_dom | 2.75e-03 | 164 | 109 | 5 | IPR000008 | |
| Domain | Ig_E-set | 3.23e-03 | 104 | 109 | 4 | IPR014756 | |
| Domain | Cadherin_CS | 3.82e-03 | 109 | 109 | 4 | IPR020894 | |
| Domain | MAM_1 | 3.84e-03 | 16 | 109 | 2 | PS00740 | |
| Domain | CCP | 3.86e-03 | 54 | 109 | 3 | SM00032 | |
| Domain | SUSHI | 4.28e-03 | 56 | 109 | 3 | PS50923 | |
| Domain | MAM | 4.33e-03 | 17 | 109 | 2 | SM00137 | |
| Domain | Acyl_Trfase/lysoPLipase | 4.33e-03 | 17 | 109 | 2 | IPR016035 | |
| Domain | CADHERIN_1 | 4.34e-03 | 113 | 109 | 4 | PS00232 | |
| Domain | Cadherin | 4.34e-03 | 113 | 109 | 4 | PF00028 | |
| Domain | CADHERIN_2 | 4.48e-03 | 114 | 109 | 4 | PS50268 | |
| Domain | - | 4.48e-03 | 114 | 109 | 4 | 2.60.40.60 | |
| Domain | Sushi_SCR_CCP_dom | 4.50e-03 | 57 | 109 | 3 | IPR000436 | |
| Domain | CA | 4.62e-03 | 115 | 109 | 4 | SM00112 | |
| Domain | Laminin_G | 4.73e-03 | 58 | 109 | 3 | IPR001791 | |
| Domain | Cadherin-like | 4.76e-03 | 116 | 109 | 4 | IPR015919 | |
| Domain | MAM | 4.86e-03 | 18 | 109 | 2 | PF00629 | |
| Domain | MAM_dom | 4.86e-03 | 18 | 109 | 2 | IPR000998 | |
| Domain | ZF_ZZ_2 | 4.86e-03 | 18 | 109 | 2 | PS50135 | |
| Domain | ZF_ZZ_1 | 4.86e-03 | 18 | 109 | 2 | PS01357 | |
| Domain | ZZ | 4.86e-03 | 18 | 109 | 2 | PF00569 | |
| Domain | MAM_2 | 4.86e-03 | 18 | 109 | 2 | PS50060 | |
| Domain | Cadherin | 5.06e-03 | 118 | 109 | 4 | IPR002126 | |
| Domain | Ig_I-set | 5.15e-03 | 190 | 109 | 5 | IPR013098 | |
| Domain | I-set | 5.15e-03 | 190 | 109 | 5 | PF07679 | |
| Domain | Znf_ZZ | 5.41e-03 | 19 | 109 | 2 | IPR000433 | |
| Domain | ZnF_ZZ | 5.41e-03 | 19 | 109 | 2 | SM00291 | |
| Pathway | REACTOME_METABOLISM_OF_LIPIDS | TPTE2 CYP51A1 SIN3A PLA2G4D B4GALT6 LCLAT1 SCAP SLC10A2 DPEP2 PLA2G4B DDHD2 PIP4K2C PCCB | 8.12e-05 | 620 | 85 | 13 | MM15193 |
| Pathway | REACTOME_SYNTHESIS_OF_PA | 8.62e-05 | 39 | 85 | 4 | M653 | |
| Pathway | REACTOME_SYNTHESIS_OF_PA | 1.05e-04 | 41 | 85 | 4 | MM14583 | |
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | EPHX1 ERBB2 B4GAT1 DSG2 CANX CYP51A1 LAMA4 RNF213 PLXNB2 PDIA4 LIFR SCAP TM9SF2 PTPRS CCDC47 ERP29 PLXNA1 DNMT1 | 4.26e-08 | 1201 | 110 | 18 | 35696571 |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | FLNC ERBB2 MYO1E FNTB AOC2 SPATA20 DYSF PLXNB2 MXRA7 NSD3 FAM83H SCAP PTPRS PLA2G4B SORBS3 ZFYVE26 PLXNA1 | 7.27e-08 | 1105 | 110 | 17 | 35748872 |
| Pubmed | Semaphorin signaling facilitates cleft formation in the developing salivary gland. | 2.18e-07 | 17 | 110 | 4 | 17626059 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | ATP5PB ERBB2 CYBRD1 B4GAT1 DTNB RNF213 ATP8B1 LCLAT1 SCAP TM9SF2 PTPRS MACF1 PCCB PCDH9 TBL2 PLXNA1 | 2.40e-07 | 1061 | 110 | 16 | 33845483 |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | ATP5PB FLNC TRAF3 KIF1A DSG2 FNTB DTNA DTNB CANX TPTE2 TNS2 PDIA4 PTPRS VARS1 TBL2 | 4.54e-07 | 974 | 110 | 15 | 28675297 |
| Pubmed | ERBB2 AFTPH MYO1E DSG2 CANX GLOD4 PLXNB2 FAM83H PDIA4 CCDC47 PCCB | 6.11e-07 | 503 | 110 | 11 | 36217030 | |
| Pubmed | Evolutionarily conserved regulators of tau identify targets for new therapies. | B4GAT1 DSG2 CANX CYP51A1 PDIA4 TM9SF2 PTPRS CCDC47 ERP29 TBL2 PLXNA1 | 7.84e-07 | 516 | 110 | 11 | 36610398 |
| Pubmed | A radial axis defined by semaphorin-to-neuropilin signaling controls pancreatic islet morphogenesis. | 9.59e-07 | 24 | 110 | 4 | 28893946 | |
| Pubmed | ATP5PB AFTPH DSG2 DTNA CANX CYP51A1 PLXNB2 MXRA7 PDIA4 LIFR CCDC47 ARL13B MACF1 ERP29 DDHD2 TBL2 EPB41L1 DNMT1 | 9.77e-07 | 1487 | 110 | 18 | 33957083 | |
| Pubmed | 1.70e-06 | 8 | 110 | 3 | 15661641 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | ATP5PB KIF1A DSG2 CANX CYP51A1 PLXNB2 LCLAT1 PDIA4 SCAP TM9SF2 CCDC47 VARS1 TBL2 DNMT1 | 1.72e-06 | 942 | 110 | 14 | 31073040 |
| Pubmed | DSG2 CANX CYP51A1 CCDC47 SUSD5 ARL13B MACF1 PCDH9 TBL2 PLXNA1 | 2.45e-06 | 467 | 110 | 10 | 30194290 | |
| Pubmed | FAM105A/OTULINL Is a Pseudodeubiquitinase of the OTU-Class that Localizes to the ER Membrane. | CANX CYP51A1 PLXNB2 LCLAT1 MXRA7 PDIA4 SCAP CCDC47 ERP29 TBL2 | 2.50e-06 | 468 | 110 | 10 | 31056421 |
| Pubmed | Irisin Mediates Effects on Bone and Fat via αV Integrin Receptors. | ATP5PB EPHX1 FLNC CANX RNF213 SIN3A PLXNB2 LCLAT1 MXRA7 PDIA4 SNED1 CLCN5 PIP4K2C METTL17 VARS1 PLXNA1 EPB41L1 | 3.14e-06 | 1451 | 110 | 17 | 30550785 |
| Pubmed | ATP5PB EPHX1 CYBRD1 CANX CYP51A1 LAMA4 SPATA20 GLOD4 PLXNB2 MXRA7 ERP29 PCCB TBL2 | 3.40e-06 | 859 | 110 | 13 | 31536960 | |
| Pubmed | DTNA DTNB CANX TPTE2 RNF213 TNS2 NSD3 PDIA4 PTPRS CCDC47 ARL13B SORBS3 EPB41L1 DNMT1 | 5.91e-06 | 1049 | 110 | 14 | 27880917 | |
| Pubmed | Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells. | EPHX1 FLNC DSG2 CANX CYP51A1 RNF213 SIN3A GLOD4 PLXNB2 MXRA7 PDIA4 FCGBP CCDC47 VARS1 TBL2 DNMT1 | 6.40e-06 | 1367 | 110 | 16 | 32687490 |
| Pubmed | 6.63e-06 | 12 | 110 | 3 | 23991118 | ||
| Pubmed | 6.63e-06 | 12 | 110 | 3 | 25839327 | ||
| Pubmed | Transmembrane semaphorin signalling controls laminar stratification in the mammalian retina. | 6.63e-06 | 12 | 110 | 3 | 21270798 | |
| Pubmed | 8.60e-06 | 13 | 110 | 3 | 10520995 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 22666441 | ||
| Pubmed | Plexin/neuropilin complexes mediate repulsion by the axonal guidance signal semaphorin 3A. | 9.91e-06 | 2 | 110 | 2 | 10781943 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 7739908 | ||
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 32510333 | ||
| Pubmed | The Endoplasmic Reticulum Chaperone Calnexin Is a NADPH Oxidase NOX4 Interacting Protein. | 9.91e-06 | 2 | 110 | 2 | 26861875 | |
| Pubmed | Transforming properties of 8p11-12 amplified genes in human breast cancer. | 9.91e-06 | 2 | 110 | 2 | 20940404 | |
| Pubmed | 9.91e-06 | 2 | 110 | 2 | 32447492 | ||
| Pubmed | Muscular dystrophies and the dystrophin-glycoprotein complex. | 9.91e-06 | 2 | 110 | 2 | 9146999 | |
| Pubmed | PDI family protein ERp29 recognizes P-domain of molecular chaperone calnexin. | 9.91e-06 | 2 | 110 | 2 | 28456374 | |
| Pubmed | 1.67e-05 | 16 | 110 | 3 | 22632726 | ||
| Pubmed | Expression of the semaphorins Sema 3D and Sema 3F in the developing parathyroid and thymus. | 1.67e-05 | 16 | 110 | 3 | 18489001 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | FNBP1 ERBB2 KIF1A DTNA DTNB RNF213 NFASC ATP8B1 ADGRV1 UBE2H PTPRS MACF1 IGSF9B PAN3 ADGRD1 EPB41L1 | 1.84e-05 | 1489 | 110 | 16 | 28611215 |
| Pubmed | B4GAT1 DSG2 CANX CYP51A1 MXRA7 FAM83H PDIA4 CCDC47 ARL13B SORBS3 ERP29 PIP4K2C PAN3 | 1.85e-05 | 1007 | 110 | 13 | 34597346 | |
| Pubmed | 2.03e-05 | 17 | 110 | 3 | 11683995 | ||
| Pubmed | 2.28e-05 | 52 | 110 | 4 | 26633812 | ||
| Pubmed | ISG15 Connects Autophagy and IFN-γ-Dependent Control of Toxoplasma gondii Infection in Human Cells. | 2.41e-05 | 268 | 110 | 7 | 33024031 | |
| Pubmed | Proteomic analysis of in vivo phosphorylated synaptic proteins. | 2.46e-05 | 53 | 110 | 4 | 15572359 | |
| Pubmed | Quantitative Proteomics Links the LRRC59 Interactome to mRNA Translation on the ER Membrane. | 2.67e-05 | 375 | 110 | 8 | 32788342 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 27397516 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 11316798 | ||
| Pubmed | Neuregulin/ErbB regulate neuromuscular junction development by phosphorylation of α-dystrobrevin. | 2.97e-05 | 3 | 110 | 2 | 22184199 | |
| Pubmed | Regulation of astrocyte activation by glycolipids drives chronic CNS inflammation. | 2.97e-05 | 3 | 110 | 2 | 25216636 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 39430739 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 25239307 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 29091353 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 16540561 | ||
| Pubmed | Normal DNA methylation dynamics in DICER1-deficient mouse embryonic stem cells. | 2.97e-05 | 3 | 110 | 2 | 22969435 | |
| Pubmed | Plexins promote Hedgehog signaling through their cytoplasmic GAP activity. | 2.97e-05 | 3 | 110 | 2 | 36169302 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 16288919 | ||
| Pubmed | Xist nucleates local protein gradients to propagate silencing across the X chromosome. | 2.97e-05 | 3 | 110 | 2 | 34813726 | |
| Pubmed | Comparable clinical outcomes in patients with HER2-mutant and EGFR-mutant lung adenocarcinomas. | 2.97e-05 | 3 | 110 | 2 | 28063177 | |
| Pubmed | PON2 ameliorates Ang II-induced cardiomyocyte injury by targeting the CANX/NOX4 signaling pathway. | 2.97e-05 | 3 | 110 | 2 | 36840500 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 16887963 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 8806646 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 28919262 | ||
| Pubmed | Application of fluorescence in situ hybridization in genome analysis of the mouse. | 2.97e-05 | 3 | 110 | 2 | 7774567 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 18625214 | ||
| Pubmed | Differential expression of plexin-A subfamily members in the mouse nervous system. | 2.97e-05 | 3 | 110 | 2 | 11241833 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 21159867 | ||
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 28890346 | ||
| Pubmed | beta-dystrobrevin, a member of the dystrophin-related protein family. | 2.97e-05 | 3 | 110 | 2 | 9419360 | |
| Pubmed | 2.97e-05 | 3 | 110 | 2 | 25237006 | ||
| Pubmed | Inherited genetic variants in autism-related CNTNAP2 show perturbed trafficking and ATF6 activation. | 2.97e-05 | 3 | 110 | 2 | 22872700 | |
| Pubmed | Expression of Cntnap2 (Caspr2) in multiple levels of sensory systems. | 2.97e-05 | 3 | 110 | 2 | 26647347 | |
| Pubmed | 4.84e-05 | 299 | 110 | 7 | 37931956 | ||
| Pubmed | DSG2 DTNA CANX CYP51A1 LCLAT1 MXRA7 PDIA4 SCAP CCDC47 PCDH9 TBL2 PLXNA1 | 4.97e-05 | 952 | 110 | 12 | 38569033 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 11306810 | ||
| Pubmed | PlexinA polymorphisms mediate the developmental trajectory of human corpus callosum microstructure. | 5.92e-05 | 4 | 110 | 2 | 25518740 | |
| Pubmed | DAMAGE, a novel alpha-dystrobrevin-associated MAGE protein in dystrophin complexes. | 5.92e-05 | 4 | 110 | 2 | 14623885 | |
| Pubmed | An interaction map of endoplasmic reticulum chaperones and foldases. | 5.92e-05 | 4 | 110 | 2 | 22665516 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 10725340 | ||
| Pubmed | A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor. | 5.92e-05 | 4 | 110 | 2 | 8570614 | |
| Pubmed | Dnmt1 activity is dispensable in δ-cells but is essential for α-cell homeostasis. | 5.92e-05 | 4 | 110 | 2 | 28119131 | |
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 16807372 | ||
| Pubmed | 5.92e-05 | 4 | 110 | 2 | 31001916 | ||
| Pubmed | A semaphorin code defines subpopulations of spinal motor neurons during mouse development. | 5.94e-05 | 24 | 110 | 3 | 15869472 | |
| Pubmed | TRAF3 DSG2 CANX CYP51A1 PLXNB2 NSD3 PDIA4 TM9SF2 CCDC47 HPRT1 SORBS3 MACF1 ERP29 DNMT1 | 6.12e-05 | 1297 | 110 | 14 | 33545068 | |
| Pubmed | Mindbomb 1, an E3 ubiquitin ligase, forms a complex with RYK to activate Wnt/β-catenin signaling. | 6.23e-05 | 67 | 110 | 4 | 21875946 | |
| Pubmed | 6.73e-05 | 25 | 110 | 3 | 23555309 | ||
| Pubmed | 8.52e-05 | 27 | 110 | 3 | 25843547 | ||
| Pubmed | Identification of phagocytosis regulators using magnetic genome-wide CRISPR screens. | 9.48e-05 | 143 | 110 | 5 | 30397336 | |
| Pubmed | 9.52e-05 | 28 | 110 | 3 | 18617019 | ||
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 25313870 | ||
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 15866882 | ||
| Pubmed | Properly formed but improperly localized synaptic specializations in the absence of laminin alpha4. | 9.85e-05 | 5 | 110 | 2 | 11369940 | |
| Pubmed | Tip60-mediated H2A.Z acetylation promotes neuronal fate specification and bivalent gene activation. | 9.85e-05 | 5 | 110 | 2 | 36417913 | |
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 20031576 | ||
| Pubmed | 9.85e-05 | 5 | 110 | 2 | 16257961 | ||
| Pubmed | Proteomic analysis of early melanosomes: identification of novel melanosomal proteins. | 1.06e-04 | 29 | 110 | 3 | 12643545 | |
| Pubmed | PIK3AP1 CCDC174 RNF213 MXRA7 PDIA4 SCAP CCDC47 DCLRE1A VARS1 DNMT1 | 1.15e-04 | 733 | 110 | 10 | 34672954 | |
| Pubmed | 1.26e-04 | 152 | 110 | 5 | 34299191 | ||
| Pubmed | PINK1 Content in Mitochondria is Regulated by ER-Associated Degradation. | 1.43e-04 | 477 | 110 | 8 | 31300519 | |
| Pubmed | Myospryn is a novel binding partner for dysbindin in muscle. | 1.47e-04 | 6 | 110 | 2 | 14688250 | |
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 19995400 | ||
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 29551912 | ||
| Pubmed | Myocilin mediates myelination in the peripheral nervous system through ErbB2/3 signaling. | 1.47e-04 | 6 | 110 | 2 | 23897819 | |
| Pubmed | 1.47e-04 | 6 | 110 | 2 | 22493095 | ||
| Pubmed | Different dystrophin-like complexes are expressed in neurons and glia. | 1.47e-04 | 6 | 110 | 2 | 10545507 | |
| Pubmed | Expression and function of semaphorin 3A and its receptors in human monocyte-derived macrophages. | 1.47e-04 | 6 | 110 | 2 | 19480842 | |
| Interaction | RHOB interactions | FNBP1 ERBB2 MYO1E DSG2 FNTB DTNA CANX PLXNB2 PTPRS HPRT1 ARL13B MACF1 PIP4K2C FMNL1 PLXNA1 EPB41L1 | 1.14e-05 | 840 | 109 | 16 | int:RHOB |
| Interaction | TAFA4 interactions | 1.18e-05 | 55 | 109 | 5 | int:TAFA4 | |
| Interaction | FBXO2 interactions | LAMA4 ADGRV1 PLXNB2 SNED1 LIFR CILP2 SCAP PTPRS PCDH9 PLXNA1 PLXNA2 | 1.42e-05 | 411 | 109 | 11 | int:FBXO2 |
| Interaction | PLXND1 interactions | 2.28e-05 | 31 | 109 | 4 | int:PLXND1 | |
| Cytoband | 15q21-q22 | 8.48e-05 | 6 | 110 | 2 | 15q21-q22 | |
| GeneFamily | Plexins | 6.13e-06 | 9 | 77 | 3 | 683 | |
| GeneFamily | Fibronectin type III domain containing | 6.17e-05 | 160 | 77 | 6 | 555 | |
| GeneFamily | C2 tensin-type domain containing|PTEN protein phosphatases|Phosphoinositide phosphatases | 1.78e-04 | 5 | 77 | 2 | 902 | |
| GeneFamily | DNAJ (HSP40) heat shock proteins|C2 tensin-type domain containing | 4.93e-04 | 8 | 77 | 2 | 837 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.84e-03 | 57 | 77 | 3 | 1179 | |
| GeneFamily | Zinc fingers ZZ-type|Lysine acetyltransferases | 2.62e-03 | 18 | 77 | 2 | 91 | |
| GeneFamily | Phospholipases|C2 domain containing phospholipases | 2.92e-03 | 19 | 77 | 2 | 832 | |
| GeneFamily | Protein disulfide isomerases | 3.57e-03 | 21 | 77 | 2 | 692 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 4.95e-03 | 161 | 77 | 4 | 593 | |
| Coexpression | GSE31082_DN_VS_CD8_SP_THYMOCYTE_DN | 2.10e-06 | 200 | 110 | 8 | M5063 | |
| Coexpression | FAN_EMBRYONIC_CTX_ASTROCYTE_2 | 4.04e-06 | 154 | 110 | 7 | M39034 | |
| Coexpression | CUI_DEVELOPING_HEART_TRABECULAR_ATRIAL_CARDIOMYOCYTE | 1.08e-05 | 179 | 110 | 7 | M39308 | |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | FLNC ERBB2 DTNA PLXNB2 LCLAT1 PDIA4 TM9SF2 PTPRS PAN3 VARS1 TBL2 PLXNA1 | 2.96e-05 | 681 | 110 | 12 | M5314 |
| Coexpression | MILI_PSEUDOPODIA_HAPTOTAXIS_DN | FLNC ERBB2 DTNA PLXNB2 LCLAT1 PDIA4 TM9SF2 PTPRS PAN3 VARS1 TBL2 PLXNA1 | 4.03e-05 | 703 | 110 | 12 | MM1055 |
| Coexpression | GSE12003_4D_VS_8D_CULTURE_MIR223_KO_BM_PROGENITOR_UP | 4.49e-05 | 152 | 110 | 6 | M405 | |
| Coexpression | NABA_ECM_AFFILIATED | 5.57e-05 | 158 | 110 | 6 | MM17063 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 8.16e-10 | 183 | 110 | 9 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.08e-09 | 189 | 110 | 9 | 6b3e88751b95fc2173f2c3d5061ed632d0c5f01c | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 1.85e-08 | 183 | 110 | 8 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | LA-13._Vascular_Smooth_Muscle|LA / Chamber and Cluster_Paper | 2.28e-08 | 188 | 110 | 8 | 34e1b074a3995aa46ab194eb45115d76d1a5514d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Mesenchymal-Myocytic_interstitial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.58e-08 | 191 | 110 | 8 | 04c4d454b57e29a8d1dcdeb4678ce71bdc29b77b | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-08 | 193 | 110 | 8 | 06b65110db974f4ef90d3511ff34428976a52c9c | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-08 | 193 | 110 | 8 | 9c16032bc03df8760ae199e8f19fdafa4c3f1827 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-08 | 193 | 110 | 8 | a4f91bca5eaa985982d33a528f7566ffde154d47 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-08 | 193 | 110 | 8 | b39d7feaac4ff8f7409cd3d15e8f3c6391367275 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.28e-08 | 197 | 110 | 8 | bf0520a94ebb1d2f94de9f526d17e0b0e8fe7052 | |
| ToppCell | AT2_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 3.41e-08 | 198 | 110 | 8 | 893036558a9ad86b57f9e735df35812e9d18739e | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-08 | 198 | 110 | 8 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.41e-08 | 198 | 110 | 8 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | Bronchial_Biopsy-Endothelial-Lymphatic|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.41e-07 | 172 | 110 | 7 | c41f5a66781bbf63afce7ca5d118cc6d8e0fe0bc | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|metastatic_Brain / Location, Cell class and cell subclass | 3.16e-07 | 179 | 110 | 7 | 56fe381ffbaba3a4f2f587a3e367b0d11fbd4a2a | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 4.25e-07 | 187 | 110 | 7 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 5.63e-07 | 195 | 110 | 7 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.83e-07 | 196 | 110 | 7 | 9830fb3da7a60f65ad463e9054bb77c06b025e4d | |
| ToppCell | PCW_10-12|World / Celltypes from embryonic and fetal-stage human lung | 6.03e-07 | 197 | 110 | 7 | 47fd8b0d596c5db1a722473c8efbb17a6bbe7538 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.67e-07 | 200 | 110 | 7 | a66449b22b39dd6987fc2c3ed160d24564234ced | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-nan|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 173 | 110 | 6 | 869da6a65d1b9b7529c666ec44e3c8ddec2ea408 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 173 | 110 | 6 | 0672bd8a4a9d18af343d01f09253fb3388896c10 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.56e-06 | 173 | 110 | 6 | 870e091ec30be01a900e1cb8b9ef1880e3b7b50d | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Degenerative_Ascending_Thin_Limb_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.71e-06 | 174 | 110 | 6 | 46bd0ef7d0541386de7a901d85d53d0176dc92bf | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-3m-Myeloid-microglial_cell|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.87e-06 | 175 | 110 | 6 | 1ea6cf9da26601646f57fa14d558a5e9e1f0b345 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Lymphatic_ECs|Endothelial_cells / Location, Cell class and cell subclass | 5.03e-06 | 176 | 110 | 6 | 42541dfe20eb29625d47c0bb79bf3c21a2460340 | |
| ToppCell | facs-Liver-Hepatocytes-24m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.29e-06 | 183 | 110 | 6 | d0721c6aa426953a520d40e976b6e65aa7ca65e8 | |
| ToppCell | COVID-19_Mild-NK_activated|COVID-19_Mild / Disease condition and Cell class | 6.29e-06 | 183 | 110 | 6 | 22bd05135906d0ecc4ba8c2e0a666093d1bf3b8f | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.49e-06 | 184 | 110 | 6 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.57e-06 | 189 | 110 | 6 | 6f2322d017b74a1757c81d6e06f50ead8c3dd0cc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-06 | 189 | 110 | 6 | 8c8ca3b30d9be6c854615459a7bfba82b427c8bc | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 7.57e-06 | 189 | 110 | 6 | 5d902a4660a27548764bf04c6de152b565da835c | |
| ToppCell | 368C-Epithelial_cells-Epithelial-E_(AT2)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.57e-06 | 189 | 110 | 6 | 926b5fa3064b501a57ba78583e8af33532add455 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.03e-06 | 191 | 110 | 6 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.03e-06 | 191 | 110 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 8.28e-06 | 192 | 110 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | 3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.28e-06 | 192 | 110 | 6 | ee9a23a4f00424a50bd7907cf3b12dc50027877e | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 8.53e-06 | 193 | 110 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 194 | 110 | 6 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 8.78e-06 | 194 | 110 | 6 | 6e13549f697f7478b34fe71f7dd9d63c5d3db22e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.04e-06 | 195 | 110 | 6 | 938b31dbf1674ee6fd0123bc88391ddcaf151217 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.04e-06 | 195 | 110 | 6 | c5f33b420c9ac14dc67fea632b8c2bc2442cbf3d | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.04e-06 | 195 | 110 | 6 | 1cdf5f296029ae424d9dba42e86a6d111e4896e6 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 9.04e-06 | 195 | 110 | 6 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Thick_Ascending_Limb_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.04e-06 | 195 | 110 | 6 | d39e9e6544f49e677ebe528c6fe60b99a3630e30 | |
| ToppCell | 3'-Pediatric_IBD-SmallIntestine-Epithelial-goblet-Goblet_cell|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.04e-06 | 195 | 110 | 6 | 219c5d0cde7f6082755154f54db221413ec555cb | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Secretory|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 9.31e-06 | 196 | 110 | 6 | 70384c1da9baed843f414cfd1403ddd586a2db07 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.31e-06 | 196 | 110 | 6 | 1522958a92e0126326a9f0d9fb1c5b5c50b001ea | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.31e-06 | 196 | 110 | 6 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.31e-06 | 196 | 110 | 6 | 1c8294014713684b50885e638668f2ce75f357f0 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 9.58e-06 | 197 | 110 | 6 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | Control-Control-Lymphocyte-T/NK-NK_activated|Control / Disease, condition lineage and cell class | 9.86e-06 | 198 | 110 | 6 | 76d5fe4e5bbe6c73a6ca409b80b5c3924e07cab7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.86e-06 | 198 | 110 | 6 | a7e5de81eb7d3d23812c179a001adbaab1506596 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.86e-06 | 198 | 110 | 6 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-05 | 199 | 110 | 6 | 5d2e85e40b6b52b1809e680b952913d77215b3d0 | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-05 | 199 | 110 | 6 | 9dd4b17fb8c70ab9e126b23b72600463f3db832d | |
| ToppCell | PCW_10-12-Mesenchymal|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.01e-05 | 199 | 110 | 6 | a09292de4c4447b8eee55d401808e43b817321cc | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-05 | 199 | 110 | 6 | 6fb5f931e6217142de38c1fffc011e63bda4772b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.01e-05 | 199 | 110 | 6 | b1753474152b82a0b811b9878c890a359e14919a | |
| ToppCell | 10x_5'_v1-Non-neoplastic-Glial-Neuronal|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-05 | 199 | 110 | 6 | 1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | e8462395fee0a532d1e7ec7f1795f28c42af6541 | |
| ToppCell | wk_15-18-Mesenchymal-Fibroblast|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.04e-05 | 200 | 110 | 6 | 4f624c3c57d1a84baa86d0830cb1b83ae110bf67 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.04e-05 | 200 | 110 | 6 | 34f52003988ce6329d8deeee1ab875fa77e01e9d | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.13e-05 | 162 | 110 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related-ICC|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.60e-05 | 165 | 110 | 5 | b1bbf5acdfc52bd8c7c7eb356d73b812eb6b908c | |
| ToppCell | 3'-GW_trimst-1.5-SmallIntestine-Mesenchymal-stromal_related|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.60e-05 | 165 | 110 | 5 | 28f8297ec7b781149cc7ac2f5e441771083b8ee3 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated-epi_ciliated_(14)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.60e-05 | 165 | 110 | 5 | 0c714e852f912b5749de4cb0895406673979b2e6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_ciliated|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 5.60e-05 | 165 | 110 | 5 | 82530f96aaefe28a13bad0474bbad043f127a86c | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 166 | 110 | 5 | 829a8998ce68739a58202851afd73e049ab0f84f | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.76e-05 | 166 | 110 | 5 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.76e-05 | 166 | 110 | 5 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | facs-Heart-LA-24m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 166 | 110 | 5 | c43aec09578975df8984886993d15b42a10190c8 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.76e-05 | 166 | 110 | 5 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 5.93e-05 | 167 | 110 | 5 | dbd2b9f2f4ba7be5fdf8318094e6b078cb1d1c43 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P2-Tnr|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.44e-05 | 87 | 110 | 4 | 0c3a3ed1f279ed29a0113cc73ae590157a4b7334 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.44e-05 | 87 | 110 | 4 | 5d1dbbd86d82cbce4f2a3365242eb92d9c821a9e | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.44e-05 | 87 | 110 | 4 | a93dbe73b337cc2d93208822728b9badf30b6870 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocyte.Tnr.Bmp4_(Bmp4)|Thalamus / BrainAtlas - Mouse McCarroll V32 | 6.44e-05 | 87 | 110 | 4 | 45ef27ba84f731e4b2188813cd6931950e5164ac | |
| ToppCell | 368C-Myeloid-Monocyte-CD16+_Monocyte|Monocyte / Donor, Lineage, Cell class and subclass (all cells) | 6.45e-05 | 170 | 110 | 5 | 4a19c7e3bb0f9c2601a10debe7000066789b4150 | |
| ToppCell | 3'_v3-bone_marrow-Mast-Mast_cell_lympho|bone_marrow / Manually curated celltypes from each tissue | 6.45e-05 | 170 | 110 | 5 | 4dedf482cd4521b3f87d2b5ae80f7a3ea8686a15 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Epithelial-epithelial_progenitor_cell|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 6.63e-05 | 171 | 110 | 5 | 3ef44a5e3e8f81424f1e9aa302860b6688a549b8 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-ASMC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.01e-05 | 173 | 110 | 5 | cb6389536195443633adb06e5f1b7483530773d1 | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 7.01e-05 | 173 | 110 | 5 | afa6bb19df52541d8d17cbfac9cbdd18a5f3632d | |
| ToppCell | droplet-Pancreas-Exocrine-21m-Epithelial-pancreatic_ductal_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.20e-05 | 174 | 110 | 5 | a0ccda8fd6f55251cdeff24cf66e72e4a31d2104 | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC-PNEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.40e-05 | 175 | 110 | 5 | 8362a46f5804333baa84cd56d450bc147f372a7e | |
| ToppCell | PND03-Epithelial-Epithelial_Airway-Neurosecretory-PNEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 7.40e-05 | 175 | 110 | 5 | 8b4c62e608f0ec84e563bbf0ebffe3ed44085298 | |
| ToppCell | facs|World / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.40e-05 | 175 | 110 | 5 | 53e96956019f984decc1c81376ebc88fbf3c4d40 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Epithelial_transtional-epithelial_cell_of_lung-Transitional_Club-AT2-Transitional_Club-AT2_L.0.4.1.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.40e-05 | 175 | 110 | 5 | dbd9dac129fb6ae5f55e7b96d04b37585458dc4a | |
| ToppCell | 3'-Child04-06-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.60e-05 | 176 | 110 | 5 | 90f36f10c6ed440a0ca549f23219398853f1fbc3 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 7.60e-05 | 176 | 110 | 5 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 7.81e-05 | 177 | 110 | 5 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.02e-05 | 178 | 110 | 5 | cc0382b0ee1e6c76522e2c86ad1425c45debab5d | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle_stem_cell|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.02e-05 | 178 | 110 | 5 | 8f31b3fac51591f7f2bcb898c07708b3e9f93a16 | |
| ToppCell | IPF-Epithelial-Mesothelial|IPF / Disease state, Lineage and Cell class | 8.45e-05 | 180 | 110 | 5 | 1fa54bf4dba72866b2295639d991af639341bc08 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-05 | 180 | 110 | 5 | 280ff5c8f292be1b88120db5ff1788b750644856 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.45e-05 | 180 | 110 | 5 | fdbd7c22044d9328a1e06e2f9a4451529d1df767 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.67e-05 | 181 | 110 | 5 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 8.67e-05 | 181 | 110 | 5 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| Disease | hereditary sensory neuropathy (is_implicated_in) | 8.07e-05 | 4 | 109 | 2 | DOID:0050548 (is_implicated_in) | |
| Disease | beta-1,4-galactosyltransferase 6 measurement | 1.34e-04 | 5 | 109 | 2 | EFO_0801411 | |
| Disease | glycocholate measurement | 1.85e-04 | 30 | 109 | 3 | EFO_0010491 | |
| Disease | pulse pressure measurement | CYBRD1 MYO1E FAT3 CYP51A1 RNF213 NOX4 DYSF PLXNB2 MXRA7 NSD3 CILP2 TRANK1 DCLRE1A DDHD2 DNMT1 | 1.86e-04 | 1392 | 109 | 15 | EFO_0005763 |
| Disease | thalamus volume | 2.83e-04 | 85 | 109 | 4 | EFO_0006935 | |
| Disease | upper face morphology measurement | 4.69e-04 | 97 | 109 | 4 | EFO_0010949 | |
| Disease | metachronous colorectal adenoma | 6.21e-04 | 45 | 109 | 3 | EFO_0803377 | |
| Disease | Gastric cancer | 7.28e-04 | 11 | 109 | 2 | cv:C0024623 | |
| Disease | Neoplasm of stomach | 7.28e-04 | 11 | 109 | 2 | cv:C0038356 | |
| Disease | GASTRIC CANCER | 7.28e-04 | 11 | 109 | 2 | 613659 | |
| Disease | lymphocyte count | PIK3AP1 TRAF3 CEL PCDHGB3 CANX IRF1 PLXNB2 SEMA3D CILP2 TM9SF2 UBE2H DDHD2 VARS1 DNMT1 | 1.00e-03 | 1464 | 109 | 14 | EFO_0004587 |
| Disease | cutaneous melanoma | 1.07e-03 | 121 | 109 | 4 | EFO_0000389 | |
| Disease | factor XI measurement, fibrinogen measurement, tissue plasminogen activator measurement, factor VII measurement | 1.18e-03 | 56 | 109 | 3 | EFO_0004619, EFO_0004623, EFO_0004694, EFO_0004791 | |
| Disease | Neoplasm of lung | 1.20e-03 | 14 | 109 | 2 | cv:C0024121 | |
| Disease | Lung cancer | 1.20e-03 | 14 | 109 | 2 | cv:C0242379 | |
| Disease | LUNG CANCER | 1.20e-03 | 14 | 109 | 2 | 211980 | |
| Disease | level of Phosphatidylethanolamine (18:1_18:1) in blood serum | 1.20e-03 | 14 | 109 | 2 | OBA_2045142 | |
| Disease | mosquito bite reaction itch intensity measurement, mosquito bite reaction size measurement | 1.40e-03 | 328 | 109 | 6 | EFO_0008377, EFO_0008378 | |
| Disease | Schizophrenia | NFASC APOH LIFR SEMA3D SLC18A2 PLA2G4B CNTNAP2 PIP4K2C PLXNA2 DNMT1 | 1.62e-03 | 883 | 109 | 10 | C0036341 |
| Disease | Benign neoplasm of stomach | 1.77e-03 | 17 | 109 | 2 | C0153943 | |
| Disease | Neoplasm of uncertain or unknown behavior of stomach | 1.77e-03 | 17 | 109 | 2 | C0496905 | |
| Disease | Carcinoma in situ of stomach | 1.77e-03 | 17 | 109 | 2 | C0154060 | |
| Disease | sporadic amyotrophic lateral sclerosis | 1.84e-03 | 140 | 109 | 4 | EFO_0001357 | |
| Disease | aspartate aminotransferase measurement | PIK3AP1 CEL RNF213 IRF1 NOX4 ATP8B1 APOH CILP2 CNTNAP2 VARS1 | 1.92e-03 | 904 | 109 | 10 | EFO_0004736 |
| Disease | Malignant Glioma | 2.24e-03 | 70 | 109 | 3 | C0555198 | |
| Disease | mixed gliomas | 2.24e-03 | 70 | 109 | 3 | C0259783 | |
| Disease | TNF-related apoptosis-inducing ligand measurement | 2.43e-03 | 72 | 109 | 3 | EFO_0008300 | |
| Disease | sexual dimorphism measurement | CYBRD1 KIF1A FNTB IRF1 APOH DYSF ADAMTS10 TRANK1 DPEP2 MACF1 EPB41L1 | 2.63e-03 | 1106 | 109 | 11 | EFO_0021796 |
| Disease | Stomach Carcinoma | 2.71e-03 | 21 | 109 | 2 | C0699791 | |
| Disease | Carcinoma of lung | 3.25e-03 | 23 | 109 | 2 | C0684249 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TFKGTPTAENPEYLG | 1236 | P04626 | |
| FSTVVPLKTFYEPGE | 31 | P02749 | |
| YSTFPPEGVFVNTLG | 191 | Q53TN4 | |
| GDGVYLPPEAFTFNI | 936 | P26358 | |
| EPFYVAGGKVPTFDE | 326 | O43505 | |
| KPEQCGPEGVTFSFF | 96 | Q6QNK2 | |
| GVGFVDFDTPDYTRP | 41 | Q6ULP2 | |
| FENPVPYTGAVKVGA | 126 | P30040 | |
| EFYGNTGVLEFKPGE | 821 | Q8WXG9 | |
| IQGEYPEDVAPTVGF | 41 | Q3SXY8 | |
| ADDIQYVFGKPFATP | 456 | P19835 | |
| PGNFYVSSESIRKGP | 566 | Q6ZUJ8 | |
| EEFFQFLYPKTGVTG | 61 | P24539 | |
| GGVYAKFAPPVQESF | 776 | O43520 | |
| VFSPASPGAGYEDVV | 711 | Q9H324 | |
| DGVYQPKIKGPFVAF | 356 | O75355 | |
| FVTYPDGRPTGDAFV | 361 | Q6NXG1 | |
| PGVQPTSVYGDFSCK | 261 | P10914 | |
| KGYVPPTGKSFAINF | 211 | P56470 | |
| PSIFSPGSVYFEKGQ | 711 | O75106 | |
| YPGSQGSPAVDKERF | 141 | Q13231 | |
| EPPFGIFVFNKDTGE | 96 | Q14126 | |
| GEYEQFESTIGFKLP | 341 | Q9H4G0 | |
| TDNGPVIPVVYDFGD | 201 | Q8WWA0 | |
| YFGPPAKNGVAAEVS | 111 | Q9BW71 | |
| EPETFPDKYSLQFGF | 441 | Q14439 | |
| PDKYSLQFGFGPFEL | 446 | Q14439 | |
| PGRVAFDGITVFYFP | 81 | Q96S65 | |
| AEGVFETEAPGGYKF | 126 | Q9HC38 | |
| YTGPGPVKDVFSTTN | 596 | P98073 | |
| GEKNFYFTGQSVIPP | 321 | Q6UWP7 | |
| FTFNVPGSGNTYPKD | 361 | Q96A33 | |
| FVGTPIDGKSEYFPT | 186 | Q9UIW2 | |
| GFVYFLTVQPETPEG | 251 | O75051 | |
| YVPDPTFENFTGGVK | 1091 | O15031 | |
| YTFDVKATDGGQPPR | 641 | Q9HC56 | |
| NDTFTVKYTPPGAGR | 826 | Q14315 | |
| IYKPEIFFAFGSPIG | 496 | O94830 | |
| EVGFPKYGAFIPSEL | 461 | P0C869 | |
| PATEGYFQPGVCFKT | 721 | Q9Y5G1 | |
| SVFYGPDPKEGLVSS | 36 | Q6PEW0 | |
| GSDKGVEIYEPFFTQ | 181 | Q7Z553 | |
| SSIYDAFPKVPEGGE | 291 | Q9UPN3 | |
| KLYIDGPFGSPFEES | 406 | Q9NPH5 | |
| GPFGSPFEESLNYEV | 411 | Q9NPH5 | |
| SVGYKPDFVGFEIPD | 171 | P00492 | |
| YIATQGPLPETFGDF | 1461 | Q13332 | |
| FVDVPGFLPGTAQEY | 391 | P05166 | |
| FIGVNGFGSPVETKY | 166 | Q58A45 | |
| DFGKGPEPESVIGYS | 806 | O94856 | |
| KVYVPTGFSAFPFEL | 391 | P07099 | |
| PYKEFFGGVSGLTVE | 261 | Q9UBX8 | |
| AYKSGFEPPGDIEFE | 271 | Q96RU3 | |
| GSVTFNGKFYPAGDV | 176 | Q9Y6R7 | |
| EPIPGVGTYDDFNTI | 76 | P51795 | |
| TTPVFGKGVAYDVPN | 141 | Q16850 | |
| NPASGEKFAYVPFGA | 436 | Q16850 | |
| QGPYFDKSFPSDVAV | 721 | Q8TDW7 | |
| PYFPDFAVVGSVKEN | 1041 | Q8TDW7 | |
| KAPVPTGEVYFADSF | 61 | P27824 | |
| KLPTAVFEGPSFGYT | 176 | O60941 | |
| VEYFGENPKTTSPGL | 971 | O95466 | |
| KLPTAVFEGPSFGYT | 176 | Q9Y4J8 | |
| ATTYFLQKPVPGFEE | 411 | P49356 | |
| GKFPQGLEDVSTYPV | 356 | Q9H4A9 | |
| APPSDYFVGQKRTGF | 391 | Q6PII3 | |
| DYEITFGGIPFSGKP | 311 | Q9UHC6 | |
| KIPGTGFTVDAFQYG | 706 | Q6PJP8 | |
| FVEEYAGSKGRFPPT | 411 | Q8TDG4 | |
| GFIEQKGSPTSAYPE | 896 | Q6ZRV2 | |
| GTGPVEFTTPVKDYS | 51 | Q12770 | |
| EFTGFPDPYTELNTG | 531 | O75923 | |
| KFPPFEEYAQHSGSG | 16 | Q00056 | |
| ESGEPYIPGVFFRQF | 236 | Q9H7H0 | |
| DNVVTGGDPFYDRFP | 831 | Q12756 | |
| NIFGTVIFAGYPPDT | 321 | P42702 | |
| PLGPGEFESFIDVYA | 341 | Q8TBX8 | |
| DPEDTVFYVGGVPSN | 976 | Q16363 | |
| VFYVGGVPSNFKLPT | 981 | Q16363 | |
| EPESSFYKANGGFQP | 331 | Q12908 | |
| LKYGAFVPPELFGSE | 491 | Q86XP0 | |
| QGFFKPEYGRPNVSA | 316 | P26640 | |
| TKVIYGNTDGPSGPF | 336 | O60279 | |
| PPGYSIKVFDFERSG | 431 | O43541 | |
| GFNTFLPPGYKIEVQ | 181 | Q96ST3 | |
| KFSKPGQPVSYTFEF | 346 | Q99457 | |
| KVEGFPTIYFAPSGD | 596 | P13667 | |
| FYPFGAERGDAVTPK | 31 | Q8TER0 | |
| AKFIGTFFIPDTYNP | 241 | O95025 | |
| GFTAYQGDFTIEVPP | 501 | Q8IUL8 | |
| PEIIFGSGFPKDQEY | 3066 | Q63HN8 | |
| QEGPTAFYKGFTPSF | 266 | P55916 | |
| FVYAIGEKFAPGPSA | 161 | Q2TAL6 | |
| SAGTPVFVPEQGGYK | 26 | Q13114 | |
| NEFPGAFPSNKYTGV | 1071 | A4D1E1 | |
| LNEFVVKFYGPQGTP | 31 | P62256 | |
| FTETPPQYIEAKEGG | 141 | Q9UPX0 | |
| DEEYGGFAEAPKFPT | 256 | Q8TB22 | |
| RTQKFGTFPGNYVAP | 656 | O60504 | |
| FQVRAFTSKGPGPYA | 1126 | P08922 | |
| VFPYVEGDKSFAEGQ | 1016 | Q9BZ95 | |
| FGERIEPSPYKFTFN | 101 | Q99805 | |
| GPPLYDDVKVQFFSS | 451 | Q6XPS3 | |
| PENYFSPSKAFEGAA | 2736 | O15050 | |
| PPFGSVLYEFVGKTA | 236 | Q05940 | |
| EVFIEGIFQPSYKSG | 2201 | Q68DK2 | |
| KTYFGAEPQPVNFVE | 131 | P48595 | |
| DGGYTFTATPEDFPK | 171 | Q9Y4P3 | |
| EPGTGFQPFLKIYQS | 316 | Q63HR2 | |
| YFEEGGTLPTPFNVI | 646 | Q9UBN4 | |
| GPVYEKPFDFPSVFQ | 171 | Q9BS34 | |
| KEEVFYGPTLPFASN | 576 | Q96NJ5 | |
| GKYFEIQFSPGGEPD | 171 | Q12965 | |
| PEEEDGEGFSFKYSP | 131 | P84157 | |
| GAPIKGYSFFPGEEE | 226 | P52961 |